RT Journal Article
SR Electronic
T1 DeepProg: an ensemble of deep-learning and machine-learning models for prognosis prediction using multi-omics data
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19010082
DO 10.1101/19010082
A1 Poirion, Olivier
A1 Chaudhary, Kumardeep
A1 Huang, Sijia
A1 Garmire, Lana X.
YR 2020
UL http://medrxiv.org/content/early/2020/06/09/19010082.abstract
AB Background Prognosis (survival) prediction of patients is important for disease management. Multi-omics data are good resources for survival prediction, however, difficult to integrate computationally.Results We introduce DeepProg, a new computational framework that robustly predicts patient survival subtypes based on multiple types of omic data. It employs an ensemble of deep-learning and machine-learning approaches to achieve high performance. We apply DeepProg on 32 cancer datasets from TCGA and discover that most cancers have two optimal survival subtypes. Patient survival risk-stratification using DeepProg is significantly better than another multi-omics data integration method called Similarity Network Fusion (p-value=7.9e-7). DeepProg shows excellent predictive accuracy in external validation cohorts, exemplified by 2 liver cancer (C-index 0.73 and 0.80) and five breast cancer datasets (C-index 0.68-0.73). Further comprehensive pan-cancer analysis unveils the genomic signatures common among all the poorest survival subtypes, with genes enriched in extracellular matrix modeling, immune deregulation, and mitosis processes.Conclusions DeepProg is a powerful and generic computational framework to predict patient survival risks. DeepProg is freely available for non-commercial use at: http://garmiregroup.org/DeepProgCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by grants K01ES025434 awarded by NIEHS through funds provided by the trans-NIH Big Data to Knowledge (BD2K) initiative (www.bd2k.nih.gov), P20 COBRE GM103457 awarded by NIH/NIGMS, R01 LM012373 and R01 LM012907 awarded by NLM, and R01 HD084633 awarded by NICHD to L.X. Garmire.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.Not ApplicableAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicableData are available upon request